8-K: Profusa Granted Nasdaq Listing Exception

Profusa, Inc. has received a favorable decision from the Nasdaq Hearings Panel, granting an exception to continue its listing on the Nasdaq Capital Market, subject to meeting specific milestones by July 6, 2026.

Summary

• Profusa, Inc. received a decision letter from the Nasdaq Hearings Panel on May 6, 2026.
• The company was granted an exception to continue its listing on the Nasdaq Capital Market.
• This exception is conditional on meeting certain interim milestones and complying with Nasdaq Listing Rule 5550(a)(2) (Bid Price Rule) and Nasdaq Listing Rule 5550(b)(2) (Equity Rule).
• Compliance with these rules must be demonstrated by July 6, 2026, in lieu of the market value of listed securities alternative.
• The company must promptly notify Nasdaq of any significant events that could affect its ability to meet the exception terms.
• The Nasdaq Panel may reconsider the exception based on future developments.
• Profusa has the right to request a review of the decision by the Nasdaq Listing and Hearing Review Council within 15 days.
• The company is evaluating the conditions and plans to take necessary actions to comply with listing criteria within the specified timeframes.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a cautiously positive development, as the company has secured an extension and a path to continued listing, but significant hurdles remain.

Positives

• Profusa has been granted an exception to continue its listing on the Nasdaq Capital Market.
• The company has a deadline of July 6, 2026, to meet specific listing requirements, providing a defined period for compliance.
• The Nasdaq Hearings Panel has provided a path forward for the company's continued listing.

Negatives

• The continued listing is subject to strict conditions, including compliance with the Bid Price Rule and Equity Rule.
• There is no assurance that Profusa will be able to meet the compliance requirements by the July 6, 2026 deadline.
• The Nasdaq Panel reserves the right to reconsider the exception based on subsequent developments.

Risks

• Failure to comply with the Bid Price Rule (Nasdaq Listing Rule 5550(a)(2)) by July 6, 2026.
• Failure to comply with the Equity Rule (Nasdaq Listing Rule 5550(b)(2)) by July 6, 2026.
• Inability to obtain required stockholder approvals for necessary actions (e.g., reverse stock split, financings).
• Execution of the compliance plan within the specified timeframes.
• Potential for the Nasdaq Panel to reconsider the exception based on future events.
• General risks associated with maintaining a Nasdaq listing, as detailed in the company's SEC filings.

Future Outlook

Profusa intends to take the necessary actions to evidence compliance with all applicable Nasdaq listing criteria within the time periods specified by the Panel. However, there can be no assurance that the Company will be able to do so. The company must also promptly notify Nasdaq of any significant events that may affect its ability to meet the terms of the exception.

Management Comments

• The Company is evaluating the conditions set forth in the Decision Letter and intends to take the actions necessary to seek to evidence compliance with all applicable listing criteria within the time periods specified by the Panel.
• There can be no assurance that the Company will be able to do so.

Industry Context

StockSavvy.ai notes that maintaining a listing on major exchanges like Nasdaq is crucial for companies, especially in the digital health sector, to access capital and maintain investor confidence. This filing indicates Profusa is actively working to meet these requirements, a common challenge for growth-stage companies.

Stakeholder Impact

• Shareholders: Continued listing on Nasdaq provides liquidity and potential for future investment, while failure to comply could lead to delisting and reduced share value.
• Employees: Maintaining Nasdaq listing can boost morale and confidence in the company's stability.
• Creditors: A stable listing status generally supports the company's financial standing.

Next Steps

• Profusa must take actions to comply with the Bid Price Rule and Equity Rule by July 6, 2026.
• The company must promptly notify Nasdaq of any significant events impacting its ability to meet the exception terms.
• Profusa may request a review of the Nasdaq Hearings Panel's decision by the Nasdaq Listing and Hearing Review Council within 15 days.

Key Dates

Recommendation

The company has secured a critical extension to maintain its Nasdaq listing, which is a positive step. However, the conditions attached and the uncertainty of meeting them by the July 6, 2026 deadline, coupled with the need for potential capital raises or stock splits, warrant a 'hold' recommendation pending clearer evidence of compliance and improved financial metrics.

Keywords

Nasdaq Listing, Profusa, Form 8-K, Bid Price Rule, Equity Rule, Capital Market, Compliance Plan, SEC Filing